Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Tofacitinib | 0.3 | uM | 1 | GRO-a | 7968.0 | 41 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | GRO-a | 6118.0 | 45 | ||||
N2586 | 1 | GRO-a | 7777.5 | 34 | |||||||
0 | GRO-a | 70.5 | 52 | ||||||||
0 | GRO-a | 39.0 | 42 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | GRO-a | 14217.0 | 51 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 12548.0 | 73 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 11199.0 | 76 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 12818.5 | 64 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 13637.0 | 54 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 6013.0 | 63 | |
RA2159 | EO1428 | 1.0 | uM | 1 | GRO-a | 5053.5 | 58 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | GRO-a | 16881.0 | 43 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 15283.0 | 34 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 12261.0 | 48 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 16003.0 | 57 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 17245.0 | 71 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | GRO-a | 15632.0 | 39 | |
N2586 | EO1428 | 1.0 | uM | 1 | GRO-a | 5433.0 | 48 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19189.5 | 62 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 19531.0 | 90 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 18097.5 | 58 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 18450.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 18757.5 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | GRO-a | 6546.0 | 55 |